# Dell Technologies Inc.: financial statements, quarterly DELL · NYSE · CIK 1571996 · [Technology](/sectors/technology.md) · fiscal year ends Jan 29 Pages: [Overview](/companies/dell.md) · [Financials](/companies/dell/financials.md) · [Filings](/companies/dell/filings.md) · [Insiders](/companies/dell/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dell/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2024 (2023-11-03) | Q4 FY2024 (2024-02-02) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-30) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [22.3](/filings/0001571996-25-000034.md) | [22.3](/filings/0001571996-25-000034.md) | [22.2](/filings/0001571996-25-000063.md) | [25.0](/filings/0001571996-25-000102.md) | [24.4](/filings/0001571996-25-000127.md) | [23.9](/filings/0001571996-25-000034.md) | [23.4](/filings/0001571996-26-000030.md) | [29.8](/filings/0001571996-26-000046.md) | [27.0](/filings/0001571996-25-000127.md) | [33.4 d](/filings/0001571996-26-000008.md) | [43.8](/filings/0001571996-26-000030.md) | [47.0](/filings/0001571996-26-000046.md) | | Cost of revenue | $bn | [17.1](/filings/0001571996-25-000034.md) | [16.9](/filings/0001571996-25-000034.md) | [17.4](/filings/0001571996-25-000063.md) | [19.7](/filings/0001571996-25-000102.md) | [19.0](/filings/0001571996-25-000127.md) | [18.3 d](/filings/0001571996-26-000008.md) | [18.4](/filings/0001571996-26-000030.md) | [24.3](/filings/0001571996-26-000046.md) | [21.4](/filings/0001571996-25-000127.md) | [26.6 d](/filings/0001571996-26-000008.md) | [36.1](/filings/0001571996-26-000030.md) | [37.1](/filings/0001571996-26-000046.md) | | Gross profit | $bn | [5.2](/filings/0001571996-25-000034.md) | [5.4](/filings/0001571996-25-000034.md) | [4.9](/filings/0001571996-25-000063.md) | [5.4](/filings/0001571996-25-000102.md) | [5.4](/filings/0001571996-25-000127.md) | [5.7](/filings/0001571996-25-000034.md) | [4.9](/filings/0001571996-26-000030.md) | [5.4](/filings/0001571996-26-000046.md) | [5.6](/filings/0001571996-25-000127.md) | [6.7 d](/filings/0001571996-26-000008.md) | [7.8](/filings/0001571996-26-000030.md) | [9.8](/filings/0001571996-26-000046.md) | | Research and development | $bn | [0.7](/filings/0001571996-24-000143.md) | [0.7 d](/filings/0001571996-26-000008.md) | [0.8](/filings/0001571996-25-000063.md) | [0.8](/filings/0001571996-25-000102.md) | [0.7](/filings/0001571996-25-000127.md) | [0.8 d](/filings/0001571996-26-000008.md) | [0.8](/filings/0001571996-26-000030.md) | [0.8](/filings/0001571996-26-000046.md) | [0.8](/filings/0001571996-25-000127.md) | [0.8 d](/filings/0001571996-26-000008.md) | [1.0](/filings/0001571996-26-000030.md) | [1.1](/filings/0001571996-26-000046.md) | | Selling, general and administrative | $bn | [3.0](/filings/0001571996-24-000143.md) | [3.1 d](/filings/0001571996-26-000008.md) | [3.1](/filings/0001571996-25-000063.md) | [3.2](/filings/0001571996-25-000102.md) | [2.9](/filings/0001571996-25-000127.md) | [2.7 d](/filings/0001571996-26-000008.md) | [3.0](/filings/0001571996-26-000030.md) | [2.9](/filings/0001571996-26-000046.md) | [2.7](/filings/0001571996-25-000127.md) | [2.8 d](/filings/0001571996-26-000008.md) | [3.1](/filings/0001571996-26-000030.md) | [3.3](/filings/0001571996-26-000046.md) | | Operating income | $bn | [1.5](/filings/0001571996-25-000034.md) | [1.5](/filings/0001571996-25-000034.md) | [1.0](/filings/0001571996-25-000063.md) | [1.4](/filings/0001571996-25-000102.md) | [1.7](/filings/0001571996-25-000127.md) | [2.2](/filings/0001571996-25-000034.md) | [1.2](/filings/0001571996-26-000030.md) | [1.8](/filings/0001571996-26-000046.md) | [2.1](/filings/0001571996-25-000127.md) | [3.1 d](/filings/0001571996-26-000008.md) | [3.7](/filings/0001571996-26-000030.md) | [5.4](/filings/0001571996-26-000046.md) | | Interest expense | $bn | [0.4](/filings/0001571996-23-000046.md) | [0.4 d](/filings/0001571996-24-000036.md) | [0.3](/filings/0001571996-24-000062.md) | [0.4](/filings/0001571996-25-000102.md) | [0.3](/filings/0001571996-25-000127.md) | [0.3 d](/filings/0001571996-26-000008.md) | [0.4](/filings/0001571996-26-000030.md) | [0.4](/filings/0001571996-25-000102.md) | [0.4](/filings/0001571996-25-000127.md) | [0.4 d](/filings/0001571996-26-000008.md) | [0.4](/filings/0001571996-26-000030.md) | not reported | | Income tax | $bn | [0.2](/filings/0001571996-25-000034.md) | [0.1](/filings/0001571996-25-000034.md) | [(0.4)](/filings/0001571996-25-000063.md) | [0.2](/filings/0001571996-25-000102.md) | [0.3](/filings/0001571996-25-000127.md) | [0.4 d](/filings/0001571996-26-000008.md) | [0.1](/filings/0001571996-26-000030.md) | [0.3](/filings/0001571996-26-000046.md) | [0.4](/filings/0001571996-25-000127.md) | [0.5 d](/filings/0001571996-26-000008.md) | [0.5](/filings/0001571996-26-000030.md) | [1.0](/filings/0001571996-26-000046.md) | | Net income | $bn | [1.1](/filings/0001571996-25-000034.md) | [1.2](/filings/0001571996-25-000034.md) | [1.0](/filings/0001571996-25-000063.md) | [0.9](/filings/0001571996-25-000102.md) | [1.2](/filings/0001571996-25-000127.md) | [1.5](/filings/0001571996-25-000034.md) | [1.0](/filings/0001571996-26-000030.md) | [1.2](/filings/0001571996-26-000046.md) | [1.5](/filings/0001571996-25-000127.md) | [2.3 d](/filings/0001571996-26-000008.md) | [3.4](/filings/0001571996-26-000030.md) | [4.1](/filings/0001571996-26-000046.md) | | Diluted EPS | $ per share | [1.42](/filings/0001571996-25-000034.md) | [1.66](/filings/0001571996-25-000034.md) | [1.37](/filings/0001571996-25-000063.md) | [1.23](/filings/0001571996-25-000102.md) | [1.64](/filings/0001571996-25-000127.md) | [2.15](/filings/0001571996-25-000034.md) | [1.37](/filings/0001571996-26-000030.md) | [1.70](/filings/0001571996-26-000046.md) | [2.28](/filings/0001571996-25-000127.md) | not reported | [5.24](/filings/0001571996-26-000030.md) | [6.34](/filings/0001571996-26-000046.md) | | Basic EPS | $ per share | [1.46](/filings/0001571996-25-000034.md) | [1.70](/filings/0001571996-25-000034.md) | [1.41](/filings/0001571996-25-000063.md) | [1.25](/filings/0001571996-25-000102.md) | [1.67](/filings/0001571996-25-000127.md) | [2.19](/filings/0001571996-25-000034.md) | [1.39](/filings/0001571996-26-000030.md) | [1.72](/filings/0001571996-26-000046.md) | [2.31](/filings/0001571996-25-000127.md) | not reported | [5.30](/filings/0001571996-26-000030.md) | [6.41](/filings/0001571996-26-000046.md) | - Revenue: us-gaap:Revenues - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2024 (2023-11-03) | FY2024 (2024-02-02) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | FY2025 (2025-01-31) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-30) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [8.3](/filings/0001571996-23-000046.md) | [7.4](/filings/0001571996-25-000034.md) | [5.8](/filings/0001571996-24-000062.md) | [4.6](/filings/0001571996-24-000090.md) | [5.2](/filings/0001571996-24-000143.md) | [3.6](/filings/0001571996-26-000008.md) | [7.7](/filings/0001571996-25-000063.md) | [8.1](/filings/0001571996-25-000102.md) | [9.6](/filings/0001571996-25-000127.md) | [11.5](/filings/0001571996-26-000046.md) | [11.6](/filings/0001571996-26-000030.md) | [11.6](/filings/0001571996-26-000046.md) | | Current assets | $bn | [37.0](/filings/0001571996-23-000046.md) | [36.0](/filings/0001571996-25-000034.md) | [34.6](/filings/0001571996-24-000062.md) | [37.5](/filings/0001571996-24-000090.md) | [38.0](/filings/0001571996-24-000143.md) | [36.2](/filings/0001571996-26-000008.md) | [42.9](/filings/0001571996-25-000063.md) | [45.5](/filings/0001571996-25-000102.md) | [43.1](/filings/0001571996-25-000127.md) | [57.6](/filings/0001571996-26-000046.md) | [70.6](/filings/0001571996-26-000030.md) | [80.5](/filings/0001571996-26-000046.md) | | Total assets | $bn | [83.3](/filings/0001571996-23-000046.md) | [82.1](/filings/0001571996-25-000034.md) | [80.2](/filings/0001571996-24-000062.md) | [82.7](/filings/0001571996-24-000090.md) | [82.0](/filings/0001571996-24-000143.md) | [79.7](/filings/0001571996-26-000008.md) | [86.9](/filings/0001571996-25-000063.md) | [89.2](/filings/0001571996-25-000102.md) | [87.5](/filings/0001571996-25-000127.md) | [101](/filings/0001571996-26-000046.md) | [115](/filings/0001571996-26-000030.md) | [127](/filings/0001571996-26-000046.md) | | Current liabilities | $bn | [48.9](/filings/0001571996-23-000046.md) | [48.4](/filings/0001571996-25-000034.md) | [47.7](/filings/0001571996-24-000062.md) | [52.0](/filings/0001571996-24-000090.md) | [49.5](/filings/0001571996-24-000143.md) | [46.5](/filings/0001571996-26-000008.md) | [50.4](/filings/0001571996-25-000063.md) | [54.9](/filings/0001571996-25-000102.md) | [50.5](/filings/0001571996-25-000127.md) | [63.3](/filings/0001571996-26-000046.md) | [74.6](/filings/0001571996-26-000030.md) | [83.7](/filings/0001571996-26-000046.md) | | Total liabilities | $bn | [85.8](/filings/0001571996-23-000046.md) | [84.3](/filings/0001571996-25-000034.md) | [82.9](/filings/0001571996-24-000062.md) | [85.5](/filings/0001571996-24-000090.md) | [84.1](/filings/0001571996-24-000143.md) | [81.1](/filings/0001571996-26-000008.md) | [89.9](/filings/0001571996-25-000063.md) | [91.9](/filings/0001571996-25-000102.md) | [90.1](/filings/0001571996-25-000127.md) | [104](/filings/0001571996-26-000046.md) | [116](/filings/0001571996-26-000030.md) | [129](/filings/0001571996-26-000046.md) | | Long-term debt | $bn | [20.1](/filings/0001571996-23-000046.md) | [19.0](/filings/0001571996-25-000034.md) | [19.4](/filings/0001571996-24-000062.md) | [17.8](/filings/0001571996-24-000090.md) | [19.4](/filings/0001571996-24-000143.md) | [19.4](/filings/0001571996-26-000008.md) | [23.9](/filings/0001571996-25-000063.md) | [21.5](/filings/0001571996-25-000102.md) | [23.8](/filings/0001571996-25-000127.md) | [23.5](/filings/0001571996-26-000046.md) | [23.6](/filings/0001571996-26-000030.md) | [26.0](/filings/0001571996-26-000046.md) | | Current portion of debt | $bn | [6.5](/filings/0001571996-23-000046.md) | [7.0](/filings/0001571996-25-000034.md) | [6.1](/filings/0001571996-24-000062.md) | [6.7](/filings/0001571996-24-000090.md) | [5.6](/filings/0001571996-24-000143.md) | [5.2](/filings/0001571996-26-000008.md) | [4.8](/filings/0001571996-25-000063.md) | [7.2](/filings/0001571996-25-000102.md) | [7.4](/filings/0001571996-25-000127.md) | [8.0](/filings/0001571996-26-000046.md) | [7.6](/filings/0001571996-26-000030.md) | [8.5](/filings/0001571996-26-000046.md) | | Shareholders' equity | $bn | [(2.7)](/filings/0001571996-23-000046.md) | [(2.2)](/filings/0001571996-25-000034.md) | [(2.8)](/filings/0001571996-24-000062.md) | [(2.9)](/filings/0001571996-24-000090.md) | [(2.3)](/filings/0001571996-24-000143.md) | [(1.5)](/filings/0001571996-26-000008.md) | [(3.0)](/filings/0001571996-25-000063.md) | [(2.8)](/filings/0001571996-25-000102.md) | [(2.6)](/filings/0001571996-25-000127.md) | [(2.5)](/filings/0001571996-26-000046.md) | [(1.4)](/filings/0001571996-26-000030.md) | [(1.4)](/filings/0001571996-26-000046.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:DebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2024 (2023-11-03) | Q4 FY2024 (2024-02-02) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-30) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [2,152 d](/filings/0001571996-24-000143.md) | [1,533 d](/filings/0001571996-26-000008.md) | [1,043](/filings/0001571996-25-000063.md) | [1,340 d](/filings/0001571996-25-000102.md) | [1,553 d](/filings/0001571996-25-000127.md) | [585 d](/filings/0001571996-26-000008.md) | [2,796](/filings/0001571996-26-000030.md) | [2,543 d](/filings/0001571996-26-000046.md) | [1,172 d](/filings/0001571996-25-000127.md) | [4,674 d](/filings/0001571996-26-000008.md) | [4,081](/filings/0001571996-26-000030.md) | [2,225 d](/filings/0001571996-26-000046.md) | | Capital expenditure | $m | [704 d](/filings/0001571996-24-000143.md) | [727 d](/filings/0001571996-26-000008.md) | [596](/filings/0001571996-25-000063.md) | [682 d](/filings/0001571996-25-000102.md) | [639 d](/filings/0001571996-25-000127.md) | [735 d](/filings/0001571996-26-000008.md) | [568](/filings/0001571996-26-000030.md) | [675 d](/filings/0001571996-26-000046.md) | [669 d](/filings/0001571996-25-000127.md) | [721 d](/filings/0001571996-26-000008.md) | [963](/filings/0001571996-26-000030.md) | [1,239 d](/filings/0001571996-26-000046.md) | | Dividends paid | $m | [266 d](/filings/0001571996-24-000143.md) | [261 d](/filings/0001571996-26-000008.md) | [336](/filings/0001571996-25-000063.md) | [316 d](/filings/0001571996-25-000102.md) | [312 d](/filings/0001571996-25-000127.md) | [311 d](/filings/0001571996-26-000008.md) | [396](/filings/0001571996-26-000030.md) | [366 d](/filings/0001571996-26-000046.md) | [351 d](/filings/0001571996-25-000127.md) | [346 d](/filings/0001571996-26-000008.md) | [464](/filings/0001571996-26-000030.md) | [405 d](/filings/0001571996-26-000046.md) | | Share repurchases | $m | [702 d](/filings/0001571996-24-000143.md) | [878 d](/filings/0001571996-26-000008.md) | [700](/filings/0001571996-25-000063.md) | [725 d](/filings/0001571996-25-000102.md) | [429 d](/filings/0001571996-25-000127.md) | [734 d](/filings/0001571996-26-000008.md) | [1,980](/filings/0001571996-26-000030.md) | [940 d](/filings/0001571996-26-000046.md) | [1,247 d](/filings/0001571996-25-000127.md) | [1,847 d](/filings/0001571996-26-000008.md) | [1,628](/filings/0001571996-26-000030.md) | [3,796 d](/filings/0001571996-26-000046.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2023 (2022-10-28) | Q4 FY2024 (2023-05-05) | Q4 FY2024 (2023-08-04) | Q3 FY2024 (2023-11-03) | Q1 FY2025 (2024-05-03) | Q2 FY2025 (2024-08-02) | Q3 FY2025 (2024-11-01) | Q1 FY2026 (2025-05-02) | Q2 FY2026 (2025-08-01) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-05-01) | Q2 FY2027 (2026-07-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [743](/filings/0001571996-23-000046.md) | [737](/filings/0001571996-24-000062.md) | [738](/filings/0001571996-24-000090.md) | [740](/filings/0001571996-24-000143.md) | [727](/filings/0001571996-25-000063.md) | [724](/filings/0001571996-25-000102.md) | [717](/filings/0001571996-25-000127.md) | [702](/filings/0001571996-26-000030.md) | [686](/filings/0001571996-26-000046.md) | [680](/filings/0001571996-25-000127.md) | [656](/filings/0001571996-26-000030.md) | [652](/filings/0001571996-26-000046.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.